TNF and inflammatory bowel disease: Similarly, it was observed an improvement of BMI and muscle parameters, described as fat free mass index, after 3 months of infliximab or adalimumab, suggesting the beneficial effect of the anti-TNF alpha therapy on the nutritional status and body composition of IBD patients (114) (Table 1).